Terms: = Germ cell tumor AND SYK, P43405, 6850, ENSG00000165025 AND Treatment
15 results:
1. SIRPB1 regulates inflammatory factor expression in the glioma microenvironment via syk: functional and bioinformatics insights.
Geng R; Zhao Y; Xu W; Ma X; Jiang Y; Han X; Zhao L; Li Y
J Transl Med; 2024 Apr; 22(1):338. PubMed ID: 38594692
[TBL] [Abstract] [Full Text] [Related]
2. RNA Sequencing in Hypoxia-Adapted T98G Glioblastoma cells Provides Supportive Evidence for IRE1 as a Potential Therapeutic Target.
White BE; Liu Y; Hakonarson H; Buono RJ
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107600
[TBL] [Abstract] [Full Text] [Related]
3. A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Kling MJ; Kesherwani V; Mishra NK; Alexander G; McIntyre EM; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
J Exp Clin Cancer Res; 2022 Nov; 41(1):321. PubMed ID: 36357906
[TBL] [Abstract] [Full Text] [Related]
4. Special issue "The advance of solid tumor research in China": Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors.
Chen L; Wang W; Jin K; Yuan B; Tan H; Sun J; Guo Y; Luo Y; Feng ST; Yu X; Chen MH; Chen J
Int J Cancer; 2023 Jan; 152(1):90-99. PubMed ID: 36111424
[TBL] [Abstract] [Full Text] [Related]
5. American Joint Committee on Cancer tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
6. syk-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.
Chen X; Kunda PE; Lin J; Zhou M; Huang J; Zhang H; Liu T
J Cancer Res Clin Oncol; 2018 Apr; 144(4):675-684. PubMed ID: 29372378
[TBL] [Abstract] [Full Text] [Related]
7. [The relationship between hypermethylation of syk gene promoter and medulloblastoma cell invasion and metastasis].
Ji HL; Shi PF; Zhou J; Mao TM; Luo YK; Chen X; Zhou KY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Feb; 32(2):132-136. PubMed ID: 29931864
[TBL] [Abstract] [Full Text] [Related]
8. syk is a target of lymphocyte-derived microparticles in the induction of apoptosis of human retinoblastoma cells.
Qiu Q; Yang C; Xiong W; Tahiri H; Payeur M; Superstein R; Carret AS; Hamel P; Ellezam B; Martin B; Vezina M; Sapieha P; Liu G; Hardy P
Apoptosis; 2015 Dec; 20(12):1613-22. PubMed ID: 26404525
[TBL] [Abstract] [Full Text] [Related]
9. Progress in Small Molecule Therapeutics for the treatment of Retinoblastoma.
Pritchard EM; Dyer MA; Guy RK
Mini Rev Med Chem; 2016; 16(6):430-54. PubMed ID: 26202204
[TBL] [Abstract] [Full Text] [Related]
10. RAC1 P29S regulates PD-L1 expression in melanoma.
Vu HL; Rosenbaum S; Purwin TJ; Davies MA; Aplin AE
Pigment Cell Melanoma Res; 2015 Sep; 28(5):590-8. PubMed ID: 26176707
[TBL] [Abstract] [Full Text] [Related]
11. BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.
Yaktapour N; Meiss F; Mastroianni J; Zenz T; Andrlova H; Mathew NR; Claus R; Hutter B; Fröhling S; Brors B; Pfeifer D; Pantic M; Bartsch I; Spehl TS; Meyer PT; Duyster J; Zirlik K; Brummer T; Zeiser R
J Clin Invest; 2014 Nov; 124(11):5074-84. PubMed ID: 25329694
[TBL] [Abstract] [Full Text] [Related]
12. Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma.
Pritchard EM; Stewart E; Zhu F; Bradley C; Griffiths L; Yang L; Suryadevara PK; Zhang J; Freeman BB; Guy RK; Dyer MA
Pharm Res; 2014 Nov; 31(11):3060-72. PubMed ID: 24906597
[TBL] [Abstract] [Full Text] [Related]
13. Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: implications for neurodegenerative diseases.
Song S; Zhou F; Chen WR
J Neuroinflammation; 2012 Sep; 9():219. PubMed ID: 22989325
[TBL] [Abstract] [Full Text] [Related]
14. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic silencing of novel tumor suppressors in malignant melanoma.
Muthusamy V; Duraisamy S; Bradbury CM; Hobbs C; Curley DP; Nelson B; Bosenberg M
Cancer Res; 2006 Dec; 66(23):11187-93. PubMed ID: 17145863
[TBL] [Abstract] [Full Text] [Related]